首页> 外国专利> Elongation factor-2 kinase (EF-2 kinase), and methods of use therefor

Elongation factor-2 kinase (EF-2 kinase), and methods of use therefor

机译:延伸因子2激酶(EF-2激酶)及其使用方法

摘要

A new superfamily of protein kinases has been discovered that centers around eukaryotic elongation factor-2 kinase (eEF-2 kinase). The protein kinases of this new superfamily have the following characteristics: 1) sequence similarity to eEF-2 kinase; 2) no sequence similarity to the protein kinases of either the serine/threonine/tyrosine kinase or histidine kinase superfamily; and, 3) specifically phosphorylates &agr;-helical regions of proteins as opposed to &bgr;-turns, as seen in all other protein kinases. Assays have been developed utilizing eEF-2 kinase and a phosphorylation target consisting of a novel &agr;-helical 16-amino acid peptide sequence to facilitate high-throughput screening for compounds that can specifically inhibit this protein kinase that has been implicated tumor growth and other hyperproliferitive disorders. Additionally, the disclosed invention includes assessing eEF-2 kinase levels for diagnostic purposes, and therapeutic formulations to inhibit eEF-2 kinase activity.
机译:已经发现了一个新的蛋白激酶超家族,其围绕真核延伸因子2激酶(eEF-2激酶)为中心。该新的超家族的蛋白激酶具有以下特征:1)与eEF-2激酶的序列相似性; 2)与丝氨酸/苏氨酸/酪氨酸激酶或组氨酸激酶超家族的蛋白激酶没有序列相似性; (3)特异性磷酸化蛋白质的α-螺旋区域,而不是β-转角,如在所有其他蛋白质激酶中所见。利用eEF-2激酶和由新的α-螺旋16-氨基酸肽序列组成的磷酸化靶标开发了测定方法,以促进高通量筛选可以特异性抑制该蛋白激酶的化合物,这些化合物与肿瘤的生长和其他有关过度增殖性疾病。另外,所公开的发明包括出于诊断目的评估eEF-2激酶水平,以及抑制eEF-2激酶活性的治疗制剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号